Original Source(s)
Related Content
Tenecteplase Fails to Boost EVT Outcomes
Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.
May 14, 2026
-
6 min
7 Days Noninferior in Bacteremia
BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.
May 12, 2026
-
5 min
FDA Approves Baxdrostat for Resistant Hypertension
Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.
May 18, 2026
-
2 min